shr-3032
Showing 1 - 1 of 1
Prevention of Graft Rejection After Organ Transplantation Trial in Beijing (SHR-3032, SHR-3032 Placebo)
Not yet recruiting
- Prevention of Graft Rejection After Organ Transplantation
- SHR-3032
- SHR-3032 Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Oct 13, 2023